BioCina
Tanya Peak is an experienced quality control professional with a comprehensive background in various roles within the pharmaceutical and biotherapeutics sectors. Currently serving as Quality Control Manager at BioCina since October 2021, Tanya oversees the Quality Control team and ensures laboratory compliance with Good Manufacturing Practices and regulatory requirements. Previously, Tanya held several key positions at Pfizer from July 2015 to October 2021, including Quality Operations Support Manager and Manufacturing Quality Manager, where responsibilities encompassed project management and team leadership in quality assurance. Tanya's earlier experience includes quality roles at Hospira, Bureau Veritas, Mayne Pharma, Gribbles Pathology, and IDEXX Laboratories. Tanya holds an MBA from the Australian Institute of Management and a Bachelor of Technology in Forensic and Analytical Chemistry from Flinders University.
This person is not in any teams
BioCina
BioCina is a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), offering highest-quality, cost-effective cell line, process, analytical and formulation development, and cGMP clinical & commercial manufacturing for the microbial, pDNA and mRNA modalities. BioCina’s first facility in Adelaide, South Australia is a testament to the quality of its work. It has a rich history of developing and manufacturing both clinical and commercial drug substance, backed by most critical SME’s having an average tenure of 15+ years at the site. BioCina boasts an elite quality record having successfully passed regulatory inspections by the US FDA, EMA and Health Canada. It is licensed by the Australian TGA for cGMP manufacturing of bulk drug substance or active intermediates. Through a partnership with NovaCina, BioCina offers clients a highest-quality fill-and-finish solution. BioCina is proud to have clients globally, including U.S., Europe, and the Asia Pacific. Because BioCina is not a drug developer, it only serves clients' products. As one of the fastest growing companies in the biopharmaceutical industry across Australia, BioCina was awarded the 2024 South Australia “Emerging Business of the Year” award. Learn more at https://biocina.com.